awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34049260-519DE541-6BFD-41F3-92D2-ED50A78EB8BD
Q34049260-519DE541-6BFD-41F3-92D2-ED50A78EB8BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34049260-519DE541-6BFD-41F3-92D2-ED50A78EB8BD
Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).
P2860
Q34049260-519DE541-6BFD-41F3-92D2-ED50A78EB8BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34049260-519DE541-6BFD-41F3-92D2-ED50A78EB8BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8d573a68e69b81c2dba079fd41b1458d14e65f19
P2860
Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.